HER2 Support Group Forums - View Single Post - Older chemo regimes: FEC reduces 10-year death risk by 48% over CMF for her2-positive

Christine MH-UK · 05-18-2006, 12:34 PM

http://www.nlm.nih.gov/medlineplus/n...ory_33672.html

Canadian researchers looked at 639 preserved specimens from pre-menopausal women and found that it may be primarily her2 positive women who benefit from anthracycline containing regimes. 'In the study, the CEF regimen reduced the 10-year risk of death for patients with HER2-positive cancers by 48 percent, compared to similar patients placed on another regimen, called CMF (cyclophosphamide, methotrexate and fluorouracil).'

Although herceptin is, of course, even better than FEC alone, I think that this is important news for patients in poorer countries where herceptin is simply unobtainable and reason why everyone breast cancer patient should have their her2 status checked.

05-18-2006, 12:34 PM	#1
Christine MH-UK Senior Member Join Date: Sep 2005 Posts: 414	Older chemo regimes: FEC reduces 10-year death risk by 48% over CMF for her2-positive http://www.nlm.nih.gov/medlineplus/n...ory_33672.html Canadian researchers looked at 639 preserved specimens from pre-menopausal women and found that it may be primarily her2 positive women who benefit from anthracycline containing regimes. 'In the study, the CEF regimen reduced the 10-year risk of death for patients with HER2-positive cancers by 48 percent, compared to similar patients placed on another regimen, called CMF (cyclophosphamide, methotrexate and fluorouracil).' Although herceptin is, of course, even better than FEC alone, I think that this is important news for patients in poorer countries where herceptin is simply unobtainable and reason why everyone breast cancer patient should have their her2 status checked.